Yantai, Shandong Province-based Chinese drug-maker Luye Pharma Group has priced its Hong Kong IPO, planning to sell 999.6 million shares at HK$5.38 to HK$5.92 each, according to media reports. This means the IPO will raise as much as US$764 million, slightly higher than previously estimated US$750 million. The IPO has already secured six cornerstone investors, […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.


Visit the original source and full text: China Money Network